 FORT WORTH, Texas, Sept. 06, 2022 GLOBE NEWSWIRE -- TFF Pharmaceuticals, Inc. NASDAQ: TFFP, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing TFF technology platform, today announced that President and CEO Glenn Mattes will be participating in the H.C. Wainwright 24th Annual Global Investment Conference being held September 12 14, 2022 at the Lotte New York Palace in New York City. Company management will also be participating in one-on-one meetings throughout the conference. 